RSS

Tag Archives: hospital performance

The Lucas critique and hospital quality

In 1976, Robert Lucas wrote a paper that articulated a common criticism of macroeconomic policy-making based on historical data. The essence of the critique was that, since the parameters of macroeconometric models were not structural, they were liable to change when other aspects of the system changed. A policy change could alter the parameters of the model; invalidating conclusions about the effects of that policy change. As one example, Lucas discussed the effect of income on consumption: a consumer, being aware of a policy change that will affect her income, will adjust her consumption with the expectation of the policy change. Thus, consumption decisions will change and will not necessarily reflect the historical relationship between income and consumption.

Lucas accepted that in the short run the estimated relationships may hold but showed that in the long run these estimated relationships were invalid. As a remedy he suggested that the focus should be on microfoundations; identifying the structural factors that determine individual decisions. But, how does this relate to hospital quality?

Estimating hospital quality is an important task for policy-makers although it is fraught with difficulty and controversy. Hospital quality may be examined in two different ways: as the effect of the hospital on the clinical outcomes of its patients (when compared to the average hospital), which we can call ‘outcomes quality’, or how well a hospital meets clinical guidelines and performs mandated tests or procedures, which we can refer to as ‘process quality’. When we conduct research into, for example, the effect of hospital volume on patient outcomes, what we are trying to uncover is how volume affects hospital outcomes quality. A policy maker wants to know how she can influence hospital quality by changing certain aspects of hospital organisation.

Recent evidence has suggested that increased competition between hospitals leads to an increase in outcomes quality, although only under fixed prices (for a recent, interesting blog on the topic including links to papers, see here). One paper showed that in areas where patients had greater choice, mortality rates and length of stay were, on average, less. This suggests that hospitals are improving in order to attract more patients. But, and this is where the Lucas critique enters, publishing information on quality will affect healthcare consumers’ decisions about which hospital to go to. Evidence is limited on the causes and correlates of hospital quality; if the higher quality hospital appears to be of high quality, its casemix, patient volume, and other variables may change. And these are the very variables that may cause the difference in hospital outcomes quality.

Studies of quality may take this change of casemix into account using appropriate controls in their analysis. In this case we may be confident that the results will hold in the short run. But, as individual preferences change, and healthcare consumers and hospitals adapt, the parameters of the model may change – they are not invariant to our policy.

Contributing to the problem, the commonly published hospital quality statistics may not be reliable. Even with casemix adjustment, the typically relied-upon measures, such as the standardised mortality ratio (SMR), may be inadequate. Mohammed et al. (2009) assessed the case mix adjustment commonly used to determine the SMR and found that, due to differences in admissions policies and coding, the effects of different variables in the casemix adjustment differed between hospitals, leading them to conclude:

“Claims that variations in hospital standardised mortality ratios from Dr Foster Unit reflect differences in quality of care are less than credible.”1

This also adds weight to the Lucas critique; these differing admissions policies will themselves be affected by a change in patient casemix that may occur due to increased competition. This would affect the validity of the casemix adjustment used in studies of hospital quality.

This is not a criticism of the validity of hospital quality studies, rather an emphasis on the importance of microfoundations. Unless we understand the factors that determine hospital quality and patient choice we cannot be sure of the long term effects of policies that, for example, affect hospital competition.

1Dr Foster Unit are one of the key providers of hospital quality stats in the UK

About these ads
 
 

Tags: , , , , , , , ,

The curse of endogeneity in the clinical literature

Endogeneity is everywhere. There is always a reason to assume that there is some endogeneity in a model; sometimes it can’t be totally eliminated and we must just reduce it to acceptable levels. Health economists produce research that often is relevant for both economics and clinical journals, but often the requirements of these two types of journal differ by quite a lot. One way they differ is that the clinical literature and biostatisticians don’t generally care about endogeneity, which is probably the exact opposite opinion of economics and econometricians. When it comes to making policy decisions, not being aware of the effects of endogeneity may have disastrous consequences. Here’s an example why.

Patient and procedure volume has been shown to be inversely correlated with clinical outcomes such as mortality. This suggests that big hospitals are good. But, what about causality? Is there any? And, if so, in which direction does it run?

The hypothesis that volume causes better outcomes is called ‘practice makes perfect’ (PMP). This could be due either to ‘learning by doing’ or ‘scale economies’. If PMP were the case then we could identify if a learning by doing mechanism was responsible either by looking at the effects of lagged volume, or by seeing if a clinician who had been at a high volume hospital ‘took’ his skills with him. The competing hypothesis is ‘selective referral’ (SR). Hospitals which have superior outcomes attract more patients which consequently boosts their volume.

In the case of a possibly simultaneous mechanism like this we resort to instrumental variables. A common instrument for volume in this case exploits the exogenous preference of individuals to go to their nearest hospital. The instrument could then be, at the patient level, the nearest hospital, or at the hospital level, the size of the catchment level.

In the clinical literature this issue of the direction of causality has often been ignored. The association of volume and positive clinical effects in some areas of medicine has led to calls for centralisation of healthcare services. This implicitly assumes that the PMP hypothesis is true, or at least plays a stronger role that SR. But what if the volume-outcome effect is driven more by SR than PMP? Then the sickest patients will all be sent to the new large hospitals which will not cause any effect to outcomes and may even have a negative effect by increasing burden on staff, inefficient use of resources, and making patients travel further among other things.

For many areas of medicine a causal link has been demonstrated between volume and outcome, and it may be shown that both PMP and SR play a role. But this is just a demonstration of the problems of ignoring endogeneity. Causal inference is demonstrated for many healthcare interventions through a randomised experiment – something which health economics could do with more of – but often it is unethical or impractical to perform such an experiment. If we do rely on observational research then economists and econometricians should be trying to communicate these issues.

 
 

Tags: , , , , , ,

Managed clinical networks

Discussions of hospital organisation focus a lot on how particular services should be arranged in order to provide high quality care without sacrificing on equity. Many studies, looking at a wide range of different procedures, have identified a benefit from volume. Those units that perform more of a certain procedure generally have better outcomes. As such there have often been calls for greater centralisation of services (e.g. see here). However, a regional, centralised service would reduce equity of access for many as the distance required to reach the hospital is increased, this could also have adverse effects on outcomes in the case of emergency operations.

One study by Gaynor et al looked at the benefits of volume in relation to coronary artery bypass grafts. They firstly found a benefit to volume of procedures. They also found that the direction of causality runs from volume to outcome by using an instrumental variables strategy which exploited the exogenous preference of people to go to their nearest hospital. They then asked why. There are two reasons why volume could affect outcomes. One is through ‘learning by doing’ – the intrinsic (see here) human capital of the staff is increased through experience, the other is through returns to scale. Using lagged volume (to see whether past volume affects present outcomes) the authors determined that the volume-outcome relationship is driven primarily by economies of scale. Another very similar and more recent study also found there to be no experience effects for this procedure. However this study also found the volume-outcome effect to be much smaller. The authors concluded that studies of patient quality should focus on more than just volume.

Standard microeconomic theory would say that if we have increasing returns to scale then we should expect there to be a point at which there are constant and decreasing returns to scale. Many studies looked at this (e.g. this, and this). This would imply then that there is a limit to centralisation.

Managed clinical networks (MCNs) could represent an organisational structure that provides the benefits of centralisation without the disadvantage of decreasing equity. Basically, a MCN is comprised of a large central unit that provides the highest intensity care and smaller peripheral units that provide lower intensity care. The network will have a strategy to get patients to the central unit if required that may entail a dedicated transport system. The ethos of a MCN is that it is the network that provides care and not an individual unit.

Besides equity and returns to scale, there are other arguments that support the use of managed clinical networks such as a more efficient use of highly specific assets. However, the key commodity to allow such a network to exist is trust; trust reduces transaction costs enough to make networks competitive against hierarchically structured units. Without it units may fear not being correctly reimbursed or they may worry that patients won’t be transferred correctly as a self-interested stakeholder holds onto lucrative patients or won’t use his slack capacity to help another unit. This would lead to excessive bureaucracy and high transaction costs.

MCNs already exist in neonatal services, some cardiac services, and diabetes primary care among others. Provided there is trust, this system of organisation could represent an efficient and equitable system of hospital organisation.

 
 

Tags: , , , , , , , ,

 
Follow

Get every new post delivered to your Inbox.

Join 522 other followers

%d bloggers like this: